[en] Thirty-six young, healthy, nonsmoking women have been selected to check the effect of low-dose oral contraceptives on hemostasis. Two identical groups were treated by Marvelon (a monophasic oral contraceptive containing ethinyl estradiol and desogestrel) or Trigynon (a triphasic oral contraceptive containing ethinyl estradiol and levonorgestrel) for a 6-month period. In the absence, previously controlled, of substantial differences between the effects of each treatment on hemostasis, all the results were pooled at the third and sixth month of the study. The effects of oral contraceptive treatment were as follows: (1) platelet number, platelet aggregating ratio, and plasma beta-thromboglobulin level were not significantly altered, and (2) antithrombin III activity was not reduced despite a slight decrease or antigen concentration. The von Willebrand factor parameters, factor VIII:C, factor VII:C, and clottable fibrinogen were significantly increased. Plasminogen (activity and antigen concentrates) and alpha 2-antiplasmin levels were also significantly increased. Activated partial thromboplastin time and euglobulin lysis time measured after venous occlusion were significantly shortened. Although statistical analysis did not show dramatic changes in all these parameters, some individual extreme values were substantially altered. Therefore we believe that these later values are worthy of cautious consideration for weighing the role that hemostasis factors might play in individual thrombotic risk.
Disciplines :
Reproductive medicine (gynecology, andrology, obstetrics)
Author, co-author :
David, Jean-Louis ; Université de Liège - ULiège > Services généraux (Faculté de médecine) > Relations académiques et scientifiques (Médecine)
GASPARD, Ulysse ; Centre Hospitalier Universitaire de Liège - CHU > Département de gynécologie-obstétrique > Service de gynécologie-obstétrique
Gillain, Daniel ; Centre Hospitalier Universitaire de Liège - CHU > Service d'Informations médico économiques (SIME)
Raskinet, Renée ; Centre Hospitalier Universitaire de Liège - CHU > Hématologie biologique et immuno hématologie
Lepot, M. R.
Language :
English
Title :
Hemostasis Profile in Women Taking Low-Dose Oral Contraceptives
Helmrich, Rosenberg, Kaufman, Strom, Shapiro (1987) Venous thromboembolism in relation to oral contraceptive use. Obstet Gynecol 69:91-95.
Meade (1988) Risks and mechanisms of cardiovascular events in users of oral contraceptives. Am J Obstet Gynecol 158:1646-1652.
Meade, Greenberg, Thompson (1980) Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50 mcg and 30 mcg estrogen preparations. Br Med J 280:1157-1161.
Bottiger, Boman, Eklund, Westerholm (1980) Oral contraceptives and thromboembolic disease, effects of lowering oestrogen content. Lancet 1:1097-10101.
Notelovitz, Kitchens, Coone, Me, Carter (1981) Low-dose oral contraceptive usage and coagulation. Am J Obstet Gynecol 141:71-75.
Notelovitz (1985) Oral contraception and coagulation. Clin Obstet Gynecol 28:73-83.
Rasi (1980) Beta-thromboglobulin in plasma False right values caused by platelet enrichment of the top layer of plasma during centrifugation. Thrombosis Research 15:543-552.
Zimmerman, Hoyer, Dickson, Edginton (1975) Determination of the von Willebrand's disease antigen (factor Vl Il-related antigen) in plasma quantitative immunoelectrophoresis. J Lab Clin Med 86:152-159.
McFarlane, Stibbe, Kirby, Zucker, Grant, McPherson (1975) A method for assaying von Willebrand factor (ristocetin cofactor). Thromb Diath Haemorrh 34:306-308.
Stormorken, Godstad, Brosstad (1983) Hereditary (l,antiplasmin deficiency. Thromb Res 31:647-651.
(1988) SAS Institute ING. SAS User's Guide. Statistics. Version 5. 188 Cary, N.C.: SAS Institute, Inc.
Rakoczi, Gero, Demeter, Gati (1985) Comparative metabolic effects of oral contraceptive preparations containing different progestogens. Drug Res 35:370-378.
Vekemans, Grippa, Capel, Fondu (1987) The effects of two low-dose contraceptives, containing ethinyl-estradiol and desogestrel or d-norgestrel. Curr Ther Res 42:1109-1118.